Alkanli, S. S. Et Al. 2023. CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease. MOLECULAR NEUROBIOLOGY , vol.60, no.3 , 1486-1498.

Alkanli, S. S., Alkanli, N., Ay, A., & Albeniz, I., (2023). CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease. MOLECULAR NEUROBIOLOGY , vol.60, no.3, 1486-1498.

Alkanli, Suleyman Et Al. "CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease," MOLECULAR NEUROBIOLOGY , vol.60, no.3, 1486-1498, 2023

Alkanli, Suleyman S. Et Al. "CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease." MOLECULAR NEUROBIOLOGY , vol.60, no.3, pp.1486-1498, 2023

Alkanli, S. S. Et Al. (2023) . "CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease." MOLECULAR NEUROBIOLOGY , vol.60, no.3, pp.1486-1498.

@article{article, author={Suleyman Serdar Alkanli Et Al. }, title={CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease}, journal={MOLECULAR NEUROBIOLOGY}, year=2023, pages={1486-1498} }